Corporate ProfileWe are a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies. Our pipeline is comprised of cell-based therapies for cancer and immune disorders. Our cellular immunotherapies are based on our novel ex vivo cell programming approach, which we apply to modulate the therapeutic function and direct the fate of hematopoietic cells.
Events & Presentations
Feb152018February 15, 2018 at 9:30 AM ESTFebruary 15, 2018
9:30 AM EST
Dec112017December 11, 2017 at 12:00 AM ESTDecember 11, 2017
12:00 AM EST